| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0950-351X(88)80029-6 |
| P698 | PubMed publication ID | 2908316 |
| P50 | author | Rajesh Thakker | Q17502119 |
| P2093 | author name string | Ponder BA | |
| P2860 | cites work | Multiple endocrine neoplasia (MEN) syndrome type IIB: gastrointestinal manifestations | Q72542985 |
| Beneficial Effect of Oral Lithium Carbonate in the Treatment of Pancreatic Cholera Syndrome | Q72851033 | ||
| Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma | Q72866285 | ||
| Malignant Glucagonoma Syndrome: Response to Chemotherapy | Q72871066 | ||
| Experimental induction of C cell tumours in thyroid by increased dietary content of vitamin D3 | Q72948044 | ||
| PANCREATIC ADENOMA WITH INTRACTABLE DIARRHEA, HYPOKALEMIA, AND HYPERCALCEMIA | Q76926557 | ||
| Coexisting Primary Hyperparathyroidism and Cushing's Syndrome | Q79059153 | ||
| Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome | Q79317677 | ||
| Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas | Q24544397 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia | Q28183532 | ||
| The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept | Q28237047 | ||
| Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals | Q30050310 | ||
| Eye manifestations in medullary carcinoma of the thyroid | Q33652185 | ||
| Carcinoid tumour of stomach and primary hyperparathyroidism: a new association | Q33837894 | ||
| Genetic aspects of adenomatosis of endocrine glands | Q34234754 | ||
| Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis | Q34235599 | ||
| Expression of recessive alleles by chromosomal mechanisms in retinoblastoma | Q34264957 | ||
| Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide | Q34493763 | ||
| High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. | Q36615464 | ||
| Primary hyperparathyroidism in a patient with Conn's syndrome | Q36716480 | ||
| Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I) | Q39245542 | ||
| Prolactin-Secreting Pituitary Adenomas in Multiple Endocrine Adenomatosis, Type I | Q39261218 | ||
| Separate pancreatic gastrin cell and beta-cell adenomas: report of a patient with multiple endocrine adenomatosis type 1. | Q39261373 | ||
| Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours | Q39429295 | ||
| Familial multiple endocrine neoplasia type I: a new look at pathophysiology | Q39465392 | ||
| Inherited forms of rickets and osteomalacia | Q39469545 | ||
| The molecular genetics of Philadelphia chromosome-positive leukemias | Q39522828 | ||
| Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy | Q39551418 | ||
| Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue | Q39568635 | ||
| Retinoblastoma and the progression of tumor genetics | Q39569339 | ||
| Oncogenes and tumor-suppressing genes | Q39629828 | ||
| Zollinger-Ellison syndrome. Current concepts in diagnosis and management | Q39670873 | ||
| Pancreatic Cholera: Beneficial Effects of Treatment with Streptozotocin | Q39921975 | ||
| The Verner-Morrison syndrome. The clinical picture and pathologic anatomy | Q39975032 | ||
| Indomethacin-Responsive Pancreatic Cholera | Q40093688 | ||
| Drugs five years later. Bromocriptine | Q40116377 | ||
| DNA restriction fragment length polymorphisms and heterozygosity in the human genome | Q40140388 | ||
| Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases | Q40200073 | ||
| Familial hypocalciuric hypercalcemia: the relation to primary parathyroid hyperplasia. | Q40332876 | ||
| Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests | Q41228727 | ||
| Dimethyltriazenoimidazole Carboxamide Therapy of Malignant Glucagonoma | Q41437213 | ||
| The association of bronchial carcinoid and pluriglandular adenomatosis | Q41876783 | ||
| Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging | Q42442283 | ||
| A familial glucagonoma syndrome: genetic, clinical and biochemical features | Q42446060 | ||
| Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies | Q42450603 | ||
| Basal and postatropine serum pancreatic polypeptide concentrations in familial multiple endocrine neoplasia type I. | Q42468715 | ||
| A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience | Q42504048 | ||
| Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes | Q43470250 | ||
| Construction of linkage maps with DNA markers for human chromosomes. | Q43486574 | ||
| Endocrine changes associated with the human aging process: III. Effect of age on the number of calcitonin immunoreactive cells in the thyroid gland | Q43767014 | ||
| Cytogenetic studies of a human medullary thyroid carcinoma cell line | Q44432163 | ||
| C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma | Q44676729 | ||
| Effect of growth hormone on vitamin D metabolism | Q44733671 | ||
| Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. | Q44802483 | ||
| Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. | Q45094261 | ||
| Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon. | Q45903853 | ||
| Subcellular fractionation of dystrophin to the triads of skeletal muscle | Q46932900 | ||
| Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma | Q48100816 | ||
| Incidence of Spontaneous Neoplasms in F344 Rats Throughout the Natural Life-Span2 | Q48457770 | ||
| Hypercalcemia in rats bearing growth hormone- and prolactin-secreting transplantable pituitary tumors | Q49316933 | ||
| Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumor of the pituitary: a syndrome with a familial incidence. | Q51341733 | ||
| Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. | Q51349913 | ||
| Suppression of insulin release by fish-insulin-induced hypoglycaemia: with reference to the diagnosis of insulinomas. | Q51678022 | ||
| A2 cell pancreatic microadenomas in a case of multiple endocrine adenomatosis. | Q54209645 | ||
| Nature of the gastric secretagogue in Zollinger-Ellison tumours. | Q54388244 | ||
| Five families with multiple endocrine adenomatosis. | Q54572292 | ||
| A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 | Q55670968 | ||
| The association of pheochromocytoma with carcinoma of the thyroid gland | Q56211630 | ||
| Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage | Q57319205 | ||
| Model for antenatal diagnosis of β-thalassaemia and other monogenic disorders by molecular analysis of linked DNA polymorphisms | Q59064456 | ||
| Gene losses in human tumours | Q59070082 | ||
| A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia | Q59080605 | ||
| Multiple endocrine neoplasia syndromes | Q62978448 | ||
| Long-term treatment of acromegaly with bromocriptine | Q67021271 | ||
| Vipoma: localisation by percutaneous transhepatic portal venous sampling | Q67435725 | ||
| Parathyroid Autotransplantation in Primary Parathyroid Hyperplasia | Q67455506 | ||
| Effect of prolactin on vitamin D metabolism | Q67786855 | ||
| Transgenic animals | Q68141987 | ||
| Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas | Q68270144 | ||
| Primary aldosteronism in a hypertensive acromegalic patient | Q68602090 | ||
| Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2 | Q68729988 | ||
| Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome | Q68907082 | ||
| Prediction of familial predisposition to retinoblastoma | Q69497732 | ||
| Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA | Q69857267 | ||
| Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy | Q69858364 | ||
| Hyperplastic and neoplastic changes in ultimobranchial remnants and in parafollicular (C) cells in bulls: a histologic and immunohistochemical study | Q69859944 | ||
| Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1 | Q69881030 | ||
| Cushing's syndrome in patients with the Zollinger-Ellison syndrome | Q69882501 | ||
| Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1 | Q69897298 | ||
| Carcinoids associated with multiple endocrine neoplasia syndromes | Q69902407 | ||
| Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995) | Q69902412 | ||
| Risk estimation and screening in families of patients with medullary thyroid carcinoma | Q69912692 | ||
| The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience | Q69912831 | ||
| Vasoactive intestinal peptide and watery-diarrhoea syndrome | Q69998199 | ||
| Human parathyroid hormone gene (PTH) is on short arm of chromosome 11 | Q70286258 | ||
| Glucagonoma as part of the polyglandular adenoma syndrome | Q70457986 | ||
| Apudomas metastatic to the liver: treatment by hepatic artery embolization | Q71014095 | ||
| Cimetidine in the treatment of Zollinger-Ellison syndrome | Q71783786 | ||
| The differential diagnosis of parathyroid adenoma and chief cell hyperplasia | Q72055205 | ||
| Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors | Q72442855 | ||
| Is preoperative localisation of insulinomas necessary? | Q72452856 | ||
| Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I | Q72538660 | ||
| P433 | issue | 4 | |
| P921 | main subject | multiple endocrine neoplasia | Q1553018 |
| P304 | page(s) | 1031-1067 | |
| P577 | publication date | 1988-11-01 | |
| P1433 | published in | Bailliere's clinical endocrinology and metabolism | Q27709241 |
| P1476 | title | Multiple endocrine neoplasia | |
| P478 | volume | 2 |
| Q34106064 | A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma |
| Q33682786 | Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma |
| Q35848798 | Molecular genetics of mineral metabolic disorders |
| Q40471503 | Multiple endocrine neoplasia type 1 (MEN 1) revisited |
| Q68085045 | Multiple endocrine neoplasia type 2 |
Search more.